Conditions: Advanced Breast Cancer; ER-positive Breast Cancer; HER2-negative Breast Cancer; ESR1 Gene Mutation
Interventions: Drug: Everolimus; Drug: Elacestrant; Drug: Placebo; Drug: Auxiliary Medicinal Product – Dexamethasone; Drug: Auxiliary Medicinal Product – Luteinizing hormone-releasing hormone (LHRH) analogues
Sponsors: MedSIR; Stemline Therapeutics, Inc.
Not yet recruiting